Clinical trial
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor
NCT05605093 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor
- Lead sponsor
- University of Minnesota
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 23, 2022
- Completion date
- October 28, 2025
- Enrollment
- 602 (actual)
- Sites
- 187
Conditions
As the registry lists them; a condition with its own page is linked.